PHARMATHENE, INC·4

Nov 23, 1:52 PM ET

FUERST THOMAS RICHARD 4

4 · PHARMATHENE, INC · Filed Nov 23, 2011

Insider Transaction Report

Form 4
Period: 2011-11-22
FUERST THOMAS RICHARD
Chief Scientific Officer
Transactions
  • Purchase

    Common Stock, $0.0001 par value per share

    2011-11-22$1.27/sh+5,000$6,35015,000 total

Documents

1 file
  • 4
    v241516_4.xmlPrimary

    OWNERSHIP DOCUMENT